Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology

被引：21

作者：

Canessa, Pier Aldo ^{[1
]}

Franceschini, Maria Cristiana ^{[2
]}

Ferro, Paola ^{[2
]}

Battolla, Enrico ^{[3
]}

Dessanti, Paolo ^{[2
]}

Manta, Carmen ^{[1
]}

Sivori, Massimiliano ^{[1
]}

Pezzi, Riccardo ^{[4
]}

Fontana, Vincenzo ^{[4
]}

Fedeli, Franco ^{[2
]}

Pistillo, Maria Pia ^{[5
]}

Roncella, Silvio ^{[2
]}

机构：

[1] Div Pneumol, La Spezia, Italy

[2] Div Histopathol & Cytopathol, La Spezia, Italy

[3] Div Clin Pathol ASL5, La Spezia, Italy

[4] IRCCS AOU San Martino IST, Epidemiol Biostat & Clin Trials Unit, Genoa, Italy

[5] IRCCS AOU San Martino IST, Tumor Genet & Epigenet Unit, Genoa, Italy

来源：

CANCER INVESTIGATION | 2013年 / 31卷 / 01期

关键词：

Cytology; ELISA; Mesothelin; Mesothelioma; Pleural effusion; Tumor; CLINICAL-SIGNIFICANCE; LUNG-CANCER; BIOMARKERS; EXPERIENCE; MANAGEMENT; PROTEINS; FLUID; SERUM;

D O I：

10.3109/07357907.2012.749265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Soluble mesothelin-related peptide (SMRP) is regarded as an FDA approved biomarker for the diagnosis and monitoring of pleural malignant mesothelioma (MPM). We detected the SMRP levels in pleural effusions (PE) by means of an ELISA and analyzed their diagnostic relevance to differentiate MPM from benign pathology and from non-MPM pleural metastasis. Comparison with cytology in MPM-PE was also performed. We found that SMRP detection in MPM-PE can help the diagnosis of MPM and provide additional diagnostic value to cytology. We concluded that SMRP test may be incorporated into clinical practice of PE from patients suspicious for MPM.

引用

收藏

页码：48 / 55

页数：8

相关论文

共 31 条

[1] Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions [J].

Aleman, Carmen ;

Manuel Porcel, Jose ;

Ma Segura, Rosa ;

Alegre, Jose ;

Esquerda, Aureli ;

Ruiz, Eva ;

Bielsa, Silvia ;

Fernandez de Sevilla, Tomas .

MEDICINA CLINICA, 2009, 133 (12) :449-453

[2]

[Anonymous], 2003, The Statistical Evaluation of Medical Tests for Classification and Prediction

[3] The management of malignant pleural mesothelioma; single centre experience in 10 years [J].

Aziz, T ;

Jilaihawi, A ;

Prakash, D .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (02) :298-305

[4] MESOMARK™:: A potential test for malignant pleural mesothelioma [J].

Beyer, Heather L. ;

Geschwindt, Ryan D. ;

Glover, Curtis L. ;

Tran, Ly ;

Hellstrom, Ingegerd ;

Hellstrom, Karl-Erik ;

Miller, M. Craig ;

Verch, Thorsten ;

Allard, W. Jeffrey ;

Pass, Harvey I. ;

Sardesai, Niranjan Y. .

CLINICAL CHEMISTRY, 2007, 53 (04) :666-672

[5] Malignant pleural mesothelioma:: Clinicopathologic and survival characteristics in a consecutive series of 394 patients [J].

Borasio, Piero ;

Berruti, Alfredo ;

Bille, Andrea ;

Lausi, Paolo ;

Levra, Matteo Giaj ;

Giardino, Roberto ;

Ardissone, Francesco .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (02) :307-313

[6] MONOCLONAL-ANTIBODY K1 REACTS WITH EPITHELIAL MESOTHELIOMA BUT NOT WITH LUNG ADENOCARCINOMA [J].

CHANG, K ;

PAI, LH ;

PASS, H ;

POGREBNIAK, HW ;

TSAO, MS ;

PASTAN, I ;

WILLINGHAM, MC .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (03) :259-268

[7] Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers [J].

Chang, K ;

Pastan, I .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :136-140

[8] Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma [J].

Creaney, Jenette ;

Yeoman, Deborah ;

Naumoff, Leanne K. ;

Hof, Michelle ;

Segal, Amanda ;

Musk, Arthur William ;

De Klerk, Nicholas ;

Horick, Nora ;

Skates, Steven J. ;

Robinson, Bruce W. S. .

THORAX, 2007, 62 (07) :569-576

[9] Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden [J].

Creaney, Jenette ;

Francis, Roslyn J. ;

Dick, Ian M. ;

Musk, Arthur W. ;

Robinson, Bruce W. S. ;

Byrne, Michael J. ;

Nowak, Anna K. .

CLINICAL CANCER RESEARCH, 2011, 17 (05) :1181-1189

[10] Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer [J].

Cristaudo, Alfonso ;

Foddis, Rudy ;

Vivaldi, Agnese ;

Guglielmi, Giovanni ;

Dipalma, Nicola ;

Filiberti, Rosangela ;

Neri, Monica ;

Ceppi, Marcello ;

Uzzi, Michela Pagan ;

Ivaldi, Gian Paolo ;

Mencoboni, Manlio ;

Canessa, PierAlclo ;

Ambrosino, Nicolino ;

Chella, Antonio ;

Mutti, Luciano ;

Puntoni, Riccardo .

CLINICAL CANCER RESEARCH, 2007, 13 (17) :5076-5081

← 1 2 3 4 →